Article
Autosomal Dominant Retinitis Pigmentosa Due to Class B Rhodopsin Mutations: An Objective Outcome for Future Treatment Trials.
International journal of molecular sciences - 27 Oct 2019
Sumaroka Alexander, Cideciyan Artur V, Charng Jason, Wu Vivian, Powers Christian A, Iyer Bhavya S, Lisi Brianna, Swider Malgorzata, Jacobson Samuel G
Abstract excerpt
Gene therapy for adRP due to RHO mutations was recently shown to prevent photoreceptor death in a canine model of Class B disease. Among translational steps to be taken, one is to determine a method to detect efficacy in a human clinical trial. The relatively slow progression of adRP becomes a difficulty for clinical trials requiring an answer to whether there is slowed progression of degeneration in response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
